Central Nervous System Infections, Cerebrospinal Fluid, HIV Infections, Meningitis, Toxoplasmosis, Toxoplasmosis, Cerebral
Conditions
Brief summary
This study looks at patients who were treated for cerebral toxoplasmosis at CHSD between 2004 and 2024. It focuses on analyzing their cerebrospinal fluid (CSF) to better understand the biological signs of the disease. The goal is to see if CSF results can show signs of meningitis, even though it's not commonly reported, and to describe any co-infections, symptoms, brain imaging findings, and patient outcomes.
Interventions
None listed
Sponsors
Centre Hospitalier de Saint-Denis
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
\- Adult patients (age 18 years) hospitalized at CHSD between January 1, 2004 and March 31, 2024 for cerebral toxoplasmosis
Exclusion criteria
\- Under 18 years ols
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 | From hospital admission to completion of diagnostic lumbar puncture and initial treatment (typically within the first 7 days of hospitalization). |
Countries
France
Outcome results
None listed